Aveanna Healthcare Holdings financials
$12.78+0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Jan 3 | FY24 Dec 28 | FY23 Dec 30 | FY22 Dec 31 | FY21 Jan 1 |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B |
| Gross profit | $810.5M | $635.5M | $595.4M | $553.2M | $412.0M |
| Gross margin | 33.3% | 31.4% | 31.4% | 30.9% | 24.5% |
| Operating income | $256.5M | $139.8M | $8.1M | -$642.2M | -$23.3M |
| Net income | $225.0M | -$10.9M | -$134.5M | -$662.0M | -$117.0M |
| Net margin | 9.2% | −0.5% | −7.1% | −37.0% | −7.0% |
| Diluted EPS | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.69 |
| EBITDA | $270.8M | $152.1M | $127.5M | $72.0M | $115.0M |
| Operating cash flow | $125.9M | $32.6M | $22.7M | -$48.4M | -$11.3M |
| Free cash flow | $118.4M | $26.3M | $16.6M | -$60.4M | -$27.3M |
| Diluted shares | 215.0M | 192.9M | 190.0M | 185.6M | 170.6M |
Balance sheet
| Period end | Jan 3 | Dec 28 | Dec 30 | Dec 31 | Jan 1 |
|---|---|---|---|---|---|
| Cash & equivalents | $193.3M | $84.3M | $43.9M | $19.2M | $30.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $1.46B | $1.45B | $1.44B | $1.43B | $1.36B |
| Total assets | $2.01B | $1.66B | $1.61B | $1.71B | $2.33B |
| Total liabilities | $1.82B | $1.79B | $1.74B | $1.72B | $1.70B |
| Shareholders' equity | $195.2M | -$122.1M | -$127.4M | -$6.3M | $638.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology